{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:25:32Z","timestamp":1787613932767,"version":"build-2736575974"},"reference-count":113,"publisher":"Bentham Science Publishers Ltd.","issue":"14","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Inflammation is the body\u2019s mechanism to trigger the immune system, thereby preventing bacteria and viruses from manifesting their toxic effect. Inflammation plays a vital role in regulating inflammatory mediator levels to initiate the wound healing process depending on the nature of the stimuli. This process occurs due to chemical release from white blood cells by elevating blood flow to the site of action, leading to redness and increased body temperature. Currently, there are numer-ous Non-steroidal anti-inflammatory drugs (NSAIDs) available, but these drugs are reported with adverse effects such as gastric bleeding, progressive kidney damage, and increased risk of heart at-tacks when prolonged use. For such instances, alternative options need to be adopted. The introduc-tion of voltage-gated ion channel blockers can be a substantial alternative to mask the side effects of these currently available drugs. Chronic inflammatory disorders such as rheumatoid and osteoarthri-tis, cancer and migraine, etc., can cause dreadful pain, which is often debilitating for the patient. The underlying mechanism for both acute and chronic inflammation involves various complex re-ceptors, different types of cells, receptors, and proteins. The working of voltage-gated sodium and calcium channels is closely linked to both inflammatory and neuropathic pain. Certain drugs such as carbamazepine and gabapentin, which are ion channel blockers, have greater pharmacotherapeutic activity for sodium and calcium channel blockers for the treatment of chronic inflammatory pain states. This review intends to provide brief information on the mechanism of action, latest clinical trials, and applications of these blockers in treating inflammatory conditions.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450123666220819141827","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T10:50:04Z","timestamp":1660992604000},"page":"1290-1303","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["An Update On Proficiency of Voltage-gated Ion Channel Blockers in the\nTreatment of Inflammation-associated Diseases"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8833-8943","authenticated-orcid":true,"given":"Angel Pavalu","family":"Godad","sequence":"first","affiliation":[{"name":"SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, Mithibai College Campus, Vaikunthlal Mehta Rd, Vile Parle West, Mumbai, Maharashtra 400056, India"},{"name":"Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddesh","family":"Kelkar","sequence":"additional","affiliation":[{"name":"MET Institute of Pharmacy, Bhujbal Knowledge City, Reclamation, Bandra West, Mumbai, Maharashtra 400050, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Nailwal","sequence":"additional","affiliation":[{"name":"SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, Mithibai College Campus, Vaikunthlal Mehta Rd, Vile Parle West, Mumbai, Maharashtra 400056, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav Yogesh","family":"Bhatia","sequence":"additional","affiliation":[{"name":"SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, Mithibai College Campus, Vaikunthlal Mehta Rd, Vile Parle West, Mumbai, Maharashtra 400056, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8490-0705","authenticated-orcid":true,"given":"Gaurav","family":"Doshi","sequence":"additional","affiliation":[{"name":"SVKM\u2019s Dr. Bhanuben Nanavati College of Pharmacy, Mithibai College Campus, Vaikunthlal Mehta Rd, Vile Parle West, Mumbai, Maharashtra 400056, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhana","family":"Sathaye","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2210-9-4","volume":"9","author":"Soli R.","year":"2009","unstructured":"Soli R.; Kaabi B.; Barhoumi M.; El-Ayeb M.; Srairi-Abid N.; Bioinformatic characterizations and prediction of K and Na ion channels effector toxins. BMC Pharmacol 2009,9,4","journal-title":"BMC Pharmacol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1111\/j.1476-5381.2011.01649_5.x","volume":"164","author":"Alexander S.P.H.","year":"2011","unstructured":"Alexander S.P.H.; Mathie A.; Peters J.A.; Ion channels. Br J Pharmacol 2011,164(Suppl. s1),S137-S174","journal-title":"Br J Pharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.apsb.2017.09.007","volume":"7","author":"Wang L.","year":"2017","unstructured":"Wang L.; Wang K.; Highlights for the 6th International Ion Channel Conference: Ion channel structure, function, disease and therapeutics. Acta Pharm Sin B 2017,7(6),665-669","journal-title":"Acta Pharm Sin B"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/B978-0-12-817728-0.00005-X","author":"Efimova E.","year":"2020","unstructured":"Efimova E.; Cardiac conduction system. Sex Cardiac Electrophysiol 2020,49-60","journal-title":"Sex Cardiac Electrophysiol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/B978-012656975-9\/50013-4","author":"Madden J.A.","year":"2001","unstructured":"Madden J.A.; Rusch N.J.; Electrophysiology of vascular smooth muscle. Heart Physiol Pathophysiol 2001,213-227","journal-title":"Heart Physiol Pathophysiol"},{"key":"ref=6","unstructured":"Ion channel | biology Britannica Available from:  [Accessed on: 2022 Feb, 15]."},{"key":"ref=7","first-page":"71","author":"Ananthanaryan P.J.C.","year":"2005","unstructured":"Ananthanaryan P.J.C.; Ananthanarayan and paniker\u2019s textbook of microbiology PDF download. In: Medicos times Orient Longman Private Limited Available from:  [Accessed on: 2022 May, 23].2005,71-80","journal-title":"In: Medicos times Orient Longman Private Limited"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/0-387-68919-2_3","author":"Bezanilla F.","year":"2007","unstructured":"Bezanilla F.; Voltage-gated ion channels. Biol Memb Ion Chann 2007,81-118","journal-title":"Biol Memb Ion Chann"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s41048-018-0074-y","volume":"4","author":"Zhang X.C.","year":"2018","unstructured":"Zhang X.C.; Yang H.; Liu Z.; Sun F.; Thermodynamics of voltage-gated ion channels. Biophysics Reports 2018,4(6),300-319","journal-title":"Biophysics Reports"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"NS20170220","DOI":"10.1042\/NS20170220","volume":"2","author":"Chew L.A.","year":"2018","unstructured":"Chew L.A.; Khanna R.; CRMP2 and voltage-gated ion channels: Potential roles in neuropathic pain. Neuronal Signal 2018,2(1),NS20170220","journal-title":"Neuronal Signal"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.vascn.2017.04.002","volume":"87","author":"Huang H.","year":"2017","unstructured":"Huang H.; Pugsley M.K.; Fermini B.; Cardiac voltage-gated ion channels in safety pharmacology: Review of the landscape leading to the CiPA initiative. J Pharmacol Toxicol Methods 2017,87,11-23","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.neuropharm.2008.06.063","volume":"56","author":"Collingridge G.L.","year":"2009","unstructured":"Collingridge G.L.; Olsen R.W.; Peters J.; Spedding M.; A nomenclature for ligand-gated ion channels. Neuropharmacology 2009,56(1),2-5","journal-title":"Neuropharmacology"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"105806","DOI":"10.1016\/j.biocel.2020.105806","volume":"126","author":"Absalom N.L.","year":"2020","unstructured":"Absalom N.L.; Liao V.W.; Chebib M.; Ligand-gated ion channels in genetic disorders and the question of efficacy. Int J Biochem Cell Biol 2020,126,105806","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1113\/JP275100","volume":"596","author":"Gielen M.","year":"2018","unstructured":"Gielen M.; Corringer P.J.; Gielen M.; Corringer P.J.; The dual-gate model for pentameric ligand-gated ion channels activation and desensitization. J Physiol 2018,596(10),1873-1902","journal-title":"J Physiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"S130","DOI":"10.1111\/bph.13879","volume":"174","author":"Alexander S.P.H.","year":"2017","unstructured":"Alexander S.P.H.; Peters J.A.; Kelly E.; The concise guide to pharmacology 2017\/18: Ligand-gated ion channels. Br J Pharmacol 2017,174(Suppl. 1),S130-S159","journal-title":"Br J Pharmacol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00424-010-0917-y","volume":"461","author":"Eisenhut M.","year":"2011","unstructured":"Eisenhut M.; Wallace H.; Ion channels in inflammation. Pflug Arch 2011,461(4),401-421","journal-title":"Pflug Arch"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s007950200015","volume":"35","author":"Hatta S.","year":"2002","unstructured":"Hatta S.; Sakamoto J.; Horio Y.; Ion channels and diseases. Med Electron Microsc 2002,35(3),117-126","journal-title":"Med Electron Microsc"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"L859","DOI":"10.1152\/ajplung.00285.2017","volume":"313","author":"Bartoszewski R.","year":"2017","unstructured":"Bartoszewski R.; Matalon S.; Collawn J.F.; Ion channels of the lung and their role in disease pathogenesis. Am J Physiol Lung Cell Mol Physiol 2017,313(5),L859-L872","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/gb-2003-4-3-207","volume":"4","author":"Yu F.H.","year":"2003","unstructured":"Yu F.H.; Catterall W.A.; Overview of the voltage-gated sodium channel family. Genome Biol 2003,4(3),207","journal-title":"Genome Biol"},{"key":"ref=20","first-page":"2372","volume":"294","author":"Ren D","year":"2001","unstructured":"Ren D; Navarro B; Xu H; Yue L; Shi Q; Clapham DE; A prokaryotic voltage-gated sodium channel. Science (1979) 2001,294(5550),2372-2375","journal-title":"Science (1979)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.1021\/jm501981g","volume":"58","author":"De Lera R.M.","year":"2015","unstructured":"De Lera R.M.; Kraus R.L.; Voltage-gated sodium channels: Structure, function, pharmacology, and clinical indications. J Med Chem 2015,58(18),7093-7118","journal-title":"J Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.tibs.2015.07.002","volume":"40","author":"Catterall W.A.","year":"2015","unstructured":"Catterall W.A.; Zheng N.; Deciphering voltage-gated Na and Ca channels by studying prokaryotic ancestors. Trends Biochem Sci 2015,40(9),526-534","journal-title":"Trends Biochem Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"18825","DOI":"10.1073\/pnas.1116449108","volume":"108","author":"De Caen P.G.","year":"2011","unstructured":"De Caen P.G.; Yarov Y.V.; Scheuer T.; Catterall W.A.; Gating charge interactions with the S1 segment during activation of a Na  channel voltage sensor. Proc Natl Acad Sci USA 2011,108(46),18825-18830","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"15142","DOI":"10.1073\/pnas.0806486105","volume":"105","author":"DeCaen P.G.","year":"2008","unstructured":"DeCaen P.G.; Yarov-Yarovoy V.; Zhao Y.; Scheuer T.; Catterall W.A.; Disulfide locking a sodium channel voltage sensor reveals ion pair formation during activation. Proc Natl Acad Sci USA 2008,105(39),15142-15147","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/164_2017_70","volume":"246","author":"Nishino A.","year":"2017","unstructured":"Nishino A.; Okamura Y.; Evolutionary history of voltage-gated sodium channels. Handb Exp Pharmacol 2017,246,3-32","journal-title":"Handb Exp Pharmacol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"10619","DOI":"10.1073\/pnas.1201884109","volume":"109","author":"Zakon H.H.","year":"2012","unstructured":"Zakon H.H.; Adaptive evolution of voltage-gated sodium channels: The first 800 million years. Proc Natl Acad Sci USA 2012,109(Suppl. 1),10619-10625","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature10238","volume":"475","author":"Payandeh J.","year":"2011","unstructured":"Payandeh J.; Scheuer T.; Zheng N.; Catterall W.A.; The crystal structure of a voltage-gated sodium channel. Nature 2011,475(7356),353-358","journal-title":"Nature"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nature11054","volume":"486","author":"Zhang X.","year":"2012","unstructured":"Zhang X.; Ren W.; Decaen P.; Crystal structure of an orthologue of the NaChBac voltage-gated sodium channel. Nature 2012,486(7401),130-134","journal-title":"Nature"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fphar.2012.00124","volume":"3","author":"Savio G.E.","year":"2012","unstructured":"Savio G.E.; Gollob M.H.; Darbar D.; Voltage-gated sodium channels: Biophysics, pharmacology, and related channelopathies. Front Pharmacol 2012,3,124","journal-title":"Front Pharmacol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/nn1754","volume":"9","author":"Yu F.H.","year":"2006","unstructured":"Yu F.H.; Mantegazza M.; Westenbroek R.E.; Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 2006,9(9),1142-1149","journal-title":"Nat Neurosci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nature05598","volume":"446","author":"Sokolov S.","year":"2007","unstructured":"Sokolov S.; Scheuer T.; Catterall W.A.; Gating pore current in an inherited ion channelopathy. Nature 2007,446(7131),76-78","journal-title":"Nature"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.hrthm.2009.09.069","volume":"7","author":"Kapplinger J.D.","year":"2010","unstructured":"Kapplinger J.D.; Tester D.J.; Alders M.; An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2010,7(1),33-46","journal-title":"Heart Rhythm"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/j.1526-4637.2009.00719.x","volume":"10","author":"Dib H.S.D.","year":"2009","unstructured":"Dib H.S.D.; Black J.A.; Waxman S.G.; Voltage-gated sodium channels: Therapeutic targets for pain. Pain Med 2009,10(7),1260-1269","journal-title":"Pain Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"12852","DOI":"10.1523\/JNEUROSCI.4015-06.2006","volume":"26","author":"Amaya F.","year":"2006","unstructured":"Amaya F.; Wang H.; Costigan M.; The voltage-gated sodium channel Na(v)1.9 is an effector of peripheral inflammatory pain hypersensitivity. J Neurosci 2006,26(50),12852-12860","journal-title":"J Neurosci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.biocel.2006.06.008","volume":"38","author":"Ekberg J.","year":"2006","unstructured":"Ekberg J.; Adams D.J.; Neuronal voltage-gated sodium channel subtypes: Key roles in inflammatory and neuropathic pain. Int J Biochem Cell Biol 2006,38(12),2005-2010","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neulet.2008.12.051","volume":"452","author":"Ritter A.M.","year":"2009","unstructured":"Ritter A.M.; Martin W.J.; Thorneloe K.S.; The voltage-gated sodium channel Nav1.9 is required for inflammation-based urinary bladder dysfunction. Neurosci Lett 2009,452(1),28-32","journal-title":"Neurosci Lett"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.conb.2008.08.017","volume":"18","author":"Momin A.","year":"2008","unstructured":"Momin A.; Wood J.N.; Sensory neuron voltage-gated sodium channels as analgesic drug targets. Curr Opin Neurobiol 2008,18(4),383-388","journal-title":"Curr Opin Neurobiol"},{"key":"ref=38","first-page":"682","volume":"12","author":"Priest B.T.","year":"2009","unstructured":"Priest B.T.; Future potential and status of selective sodium channel blockers for the treatment of pain. Curr Opin Drug Discov Devel 2009,12(5),682-692","journal-title":"Curr Opin Drug Discov Devel"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fphar.2011.00054","volume":"2","author":"Theile J.W.","year":"2011","unstructured":"Theile J.W.; Cummins T.R.; Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes. Front Pharmacol 2011,2,54","journal-title":"Front Pharmacol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.nurt.2009.08.001","volume":"6","author":"Bhattacharya A.","year":"2009","unstructured":"Bhattacharya A.; Wickenden A.D.; Chaplan S.R.; Sodium channel blockers for the treatment of neuropathic pain. Neurotherapeutics 2009,6(4),663-678","journal-title":"Neurotherapeutics"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2174\/156802609788317883","volume":"9","author":"Matulenko M.","year":"2009","unstructured":"Matulenko M.; Scanio M.; Kort M.; Voltage-gated sodium channel blockers for the treatment of chronic pain. Curr Top Med Chem 2009,9(4),362-376","journal-title":"Curr Top Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"a003947","DOI":"10.1101\/cshperspect.a003947","volume":"3","author":"Catterall W.A.","year":"2011","unstructured":"Catterall W.A.; Voltage-gated calcium channels. Cold Spring Harb Perspect Biol 2011,3(8),a003947","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/bs.armc.2020.03.003","volume":"55","author":"Shilpi J.A.","year":"2020","unstructured":"Shilpi J.A.; Uddin S.J.; Analgesic and antipyretic natural products. Annu Rep Med Chem 2020,55,435-458","journal-title":"Annu Rep Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuron.2014.03.016","volume":"82","author":"Simms B.A.","year":"2014","unstructured":"Simms B.A.; Zamponi G.W.; Neuronal voltage-gated calcium channels: Structure, function, and dysfunction. Neuron 2014,82(1),24-45","journal-title":"Neuron"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbrc.2015.02.110","volume":"460","author":"Hogan P.G.","year":"2015","unstructured":"Hogan P.G.; Rao A.; Store-operated calcium entry: Mechanisms and modulation. Biochem Biophys Res Commun 2015,460(1),40-49","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1085\/jgp.201311153","volume":"143","author":"Ben J.M.","year":"2014","unstructured":"Ben J.M.; Yue D.T.; Calmodulin regulation (calmodulation) of voltage-gated calcium channels. J Gen Physiol 2014,143(6),679-692","journal-title":"J Gen Physiol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1469-8137.2010.03271.x","volume":"187","author":"Verret F.","year":"2010","unstructured":"Verret F.; Wheeler G.; Taylor A.R.; Farnham G.; Brownlee C.; Calcium channels in photosynthetic eukaryotes: Implications for evolution of calcium\u2010based signalling. New Phytol 2010,187(1),23-43","journal-title":"New Phytol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3389\/fphys.2016.00481","volume":"7","author":"Senatore A.","year":"2016","unstructured":"Senatore A.; Raiss H.; Le P.; Physiology and evolution of voltage-gated calcium channels in early diverging animal phyla: Cnidaria, placozoa, porifera and ctenophora. Front Physiol 2016,7,481","journal-title":"Front Physiol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1038\/sj.bjp.0706442","volume":"147","author":"Dolphin A.C.","year":"2006","unstructured":"Dolphin A.C.; A short history of voltage-gated calcium channels. Br J Pharmacol 2006,147(S1),S56-S62","journal-title":"Br J Pharmacol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/pr.57.4.5","volume":"57","author":"Catterall W.A.","year":"2005","unstructured":"Catterall W.A.; Perez R.E.; Snutch T.P.; Striessnig J.; International union of pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 2005,57(4),411-425","journal-title":"Pharmacol Rev"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1113\/JP272262","volume":"594","author":"Dolphin A.C.","year":"2016","unstructured":"Dolphin A.C.; Voltage-gated calcium channels and their auxiliary subunits: Physiology and pathophysiology and pharmacology. J Physiol 2016,594(19),5369-5390","journal-title":"J Physiol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1073\/pnas.0908735107","volume":"107","author":"Davies A.","year":"2010","unstructured":"Davies A.; Kadurin I.; Alvarez-Laviada A.; The \u03b1  \u03b4 subunits of voltage-gated calcium channels form GPI-anchored proteins, a posttranslational modification essential for function. Proc Natl Acad Sci USA 2010,107(4),1654-1659","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/jmedgenet-2012-101223","volume":"50","author":"Edvardson S.","year":"2013","unstructured":"Edvardson S.; Oz S.; Abulhijaa F.A.; Early infantile epileptic encephalopathy associated with a high voltage gated calcium channelopathy. J Med Genet 2013,50(2),118-123","journal-title":"J Med Genet"},{"key":"ref=54","first-page":"1169","volume":"1763","author":"Bidaud I.","year":"2006","unstructured":"Bidaud I.; Mezghrani A.; Swayne L.A.; Monteil A.; Lory P.; Voltage-gated calcium channels in genetic diseases. Biochimica et Biophysica Acta (BBA) -. Mol Cell Res 2006,1763(11),1169-1174","journal-title":"Mol Cell Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1385\/MN:25:1:031","volume":"25","author":"Pietrobon D.","year":"2002","unstructured":"Pietrobon D.; Calcium channels and channelopathies of the central nervous system. Mol Neurobiol 2002,25(1),31-50","journal-title":"Mol Neurobiol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1359-6446(05)03662-7","volume":"11","author":"McGivern J.G.","year":"2006","unstructured":"McGivern J.G.; Targeting N-type and T-type calcium channels for the treatment of pain. Drug Discov Today 2006,11(5-6),245-253","journal-title":"Drug Discov Today"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.brainresrev.2008.12.021","volume":"60","author":"Zamponi G.W.","year":"2009","unstructured":"Zamponi G.W.; Lewis R.J.; Todorovic S.M.; Arneric S.P.; Snutch T.P.; Role of voltage-gated calcium channels in ascending pain pathways. Brain Res Brain Res Rev 2009,60(1),84-89","journal-title":"Brain Res Brain Res Rev"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.trap.2010.03.003","volume":"14","author":"Doan L.","year":"2010","unstructured":"Doan L.; Voltage-gated calcium channels and pain. Tech Reg Anesth Pain Manage 2010,14(2),42-47","journal-title":"Tech Reg Anesth Pain Manage"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/j.1476-5381.2012.02082.x","volume":"167","author":"Vink S.","year":"2012","unstructured":"Vink S.; Alewood P.F.; Targeting voltage-gated calcium channels: Developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain. Br J Pharmacol 2012,167(5),970-989","journal-title":"Br J Pharmacol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.amjmed.2003.08.027","volume":"116","author":"Eisenberg M.J.","year":"2004","unstructured":"Eisenberg M.J.; Brox A.; Bestawros A.N.; Calcium channel blockers: An update. Am J Med 2004,116(1),35-43","journal-title":"Am J Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/bph.12240","volume":"169","author":"Nimmrich V.","year":"2013","unstructured":"Nimmrich V.; Eckert A.; Calcium channel blockers and dementia. Br J Pharmacol 2013,169(6),1203-1210","journal-title":"Br J Pharmacol"},{"key":"ref=62","first-page":"689","author":"Taddei S.","year":"2018","unstructured":"Taddei S.; Bruno R.M.; Calcium channel blockers. Encyclopedia of Endocrine Diseases 2018,689-695","journal-title":"Encyclopedia of Endocrine Diseases"},{"key":"ref=63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002255.pub2","volume":"2014","author":"Flenady V.","year":"2014","unstructured":"Flenady V.; Wojcieszek A.M.; Papatsonis D.N.M.; Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database of Syst Rev 2014,2014(6)","journal-title":"Cochrane Database of Syst Rev"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-817070-0.00001-4","author":"Aria M.M.","year":"2020","unstructured":"Aria M.M.; Bioelectricity and excitable membranes. Electrophysiol Measurements Study Neural Interfaces 2020,1-23","journal-title":"Electrophysiol Measurements Study Neural Interfaces"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nature00978","volume":"419","author":"Yellen G.","year":"2002","unstructured":"Yellen G.; The voltage-gated potassium channels and their relatives. Nature 2002,419(6902),35-42","journal-title":"Nature"},{"key":"ref=66","unstructured":"Voltage-Gated K+ channels. Available from:  [Accessed on: 2022 Feb, 11]."},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/35102000","volume":"414","author":"Morais-Cabral J.H.","year":"2001","unstructured":"Morais-Cabral J.H.; Zhou Y.; MacKinnon R.; Energetic optimization of ion conduction rate by the K selectivity filter. Nature 2001,414(6859),37-42","journal-title":"Nature"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/35102009","volume":"414","author":"Zhou Y.","year":"2001","unstructured":"Zhou Y.; Morais C.J.H.; Kaufman A.; Mackinnon R.; Chemistry of ion coordination and hydration revealed by a K channel-Fab complex at 2.0 \u00c5 resolution. Nature 2001,414(6859),43-48","journal-title":"Nature"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1242\/jeb.110270","volume":"218","author":"Moran Y.","year":"2015","unstructured":"Moran Y.; Barzilai M.G.; Liebeskind B.J.; Zakon H.H.; Evolution of voltage-gated ion channels at the emergence of Metazoa. J Exp Biol 2015,218(4),515-525","journal-title":"J Exp Biol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/nsmb1309","volume":"14","author":"Cordero M.J.F.","year":"2007","unstructured":"Cordero M.J.F.; Jogini V.; Lewis A.; Molecular driving forces determining potassium channel slow inactivation. Nat Struct Mol Biol 2007,14(11),1062-1069","journal-title":"Nat Struct Mol Biol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrn2148","volume":"8","author":"Bean B.P.","year":"2007","unstructured":"Bean B.P.; The action potential in mammalian central neurons. Nature Rev Neurosci 2007,8(6),451-465","journal-title":"Nature Rev Neurosci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/B978-0-12-378630-2.00133-X","author":"Catterall W.A.","year":"2013","unstructured":"Catterall W.A.; Ion channel protein superfamily. Encycl Biol Chem 2013,648-652","journal-title":"Encycl Biol Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/B978-0-12-386931-9.00013-1","volume":"117","author":"Herguedas B.","year":"2013","unstructured":"Herguedas B.; Krieger J.; Greger I.H.; Receptor heteromeric assembly-how it works and why it matters: The case of ionotropic glutamate receptors. Prog Mol Biol Transl Sci 2013,117,361-386","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/B978-0-12-821913-3.00009-3","author":"Smith M.","year":"2021","unstructured":"Smith M.; Epilepsy and movement disorders. Mecha Genet Neurodevel Cognitive Disord 2021,195-224","journal-title":"Mecha Genet Neurodevel Cognitive Disord"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/mus.20536","volume":"33","author":"Maddison P.","year":"2006","unstructured":"Maddison P.; Mills K.R.; Newsom D.J.; Clinical electrophysiological characterization of the acquired neuromyotonia phenotype of autoimmune peripheral nerve hyperexcitability. Muscle Nerve 2006,33(6),801-808","journal-title":"Muscle Nerve"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/B978-0-444-63432-0.00011-6","volume":"133","author":"Irani S.R.","year":"2016","unstructured":"Irani S.R.; Vincent A.; Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes. Handb Clin Neurol 2016,133,185-197","journal-title":"Handb Clin Neurol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1523\/JNEUROSCI.23-13-05572.2003","volume":"23","author":"Olsen M.L.","year":"2003","unstructured":"Olsen M.L.; Schade S.; Lyons S.A.; Amaral M.D.; Sontheimer H.; Expression of voltage-gated chloride channels in human glioma cells. J Neurosci 2003,23(13),5572-5582","journal-title":"J Neurosci"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1469-7793.2001.0661e.x","volume":"532","author":"Wondergem R.","year":"2001","unstructured":"Wondergem R.; Gong W.; Monen S.H.; Blocking swelling\u2010activated chloride current inhibits mouse liver cell proliferation. J Physiol 2001,532(3),661-672","journal-title":"J Physiol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0006-291X(05)81485-8","volume":"187","author":"Tilly B.C.","year":"1992","unstructured":"Tilly B.C.; Mancini G.M.S.; Bijman J.; Nucleotide-activated chloride channels in lysosomal membranes. Biochem Biophys Res Commun 1992,187(1),254-260","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1113\/jphysiol.1989.sp017830","volume":"418","author":"Matthews G.","year":"1989","unstructured":"Matthews G.; Neher E.; Penner R.; Matthews G.; Neher E.; Penner R.; Second messenger-activated calcium influx in rat peritoneal mast cells. J Physiol 1989,418(1),105-130","journal-title":"J Physiol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1006\/geno.1995.1015","volume":"27","author":"Borsani G.","year":"1995","unstructured":"Borsani G.; Rugarli E.I.; Taglialatela M.; Wong C.; Ballabio A.; Characterization of a human and murine gene (CLCN3) sharing similarities to voltage-gated chloride channels and to a yeast integral membrane protein. Genomics 1995,27(1),131-141","journal-title":"Genomics"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0896-6273(00)80030-6","volume":"16","author":"Ranganathan R.","year":"1996","unstructured":"Ranganathan R.; Lewis J.H.; MacKinnon R.; Spatial localization of the K channel selectivity filter by mutant cycle-based structure analysis. Neuron 1996,16(1),131-139","journal-title":"Neuron"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/science.7716526","volume":"268","author":"L\u00fc Q.","year":"1995","unstructured":"L\u00fc Q.; Miller C.; Silver as a probe of pore-forming residues in a potassium channel. Science 1995,268(5208),304-307","journal-title":"Science"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/ng0493-305","volume":"3","author":"George A.L.","year":"1993","unstructured":"George A.L.; Crackower M.A.; Abdalla J.A.; Hudson A.J.; Ebers G.C.; Molecular basis of Thomsen\u2019s disease (autosomal dominant myotonia congenita). Nat Genet 1993,3(4),305-310","journal-title":"Nat Genet"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1073\/pnas.94.6.2729","volume":"94","author":"Fahlke C.","year":"1997","unstructured":"Fahlke C.; Beck C.L.; George A.L.; A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel. Proc Natl Acad Sci USA 1997,94(6),2729-2734","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/348510a0","volume":"348","author":"Jentsch T.J.","year":"1990","unstructured":"Jentsch T.J.; Steinmeyer K.; Schwarz G.; Primary structure of Torpedo marmorata chloride channel isolated by expression cloning in Xenopus oocytes. Nature 1990,348(6301),510-514","journal-title":"Nature"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/360759a0","volume":"360","author":"Gr\u00fcnder S.","year":"1992","unstructured":"Gr\u00fcnder S.; Thiemann A.; Pusch M.; Jentsch T.J.; Regions involved in the opening of CIC-2 chloride channel by voltage and cell volume. Nature 1992,360(6406),759-762","journal-title":"Nature"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"6943","DOI":"10.1073\/pnas.91.15.6943","volume":"91","author":"Kieferle S.","year":"1994","unstructured":"Kieferle S.; Fong P.; Bens M.; Vandewalle A.; Jentsch T.J.; Two highly homologous members of the ClC chloride channel family in both rat and human kidney. Proc Natl Acad Sci USA 1994,91(15),6943-6947","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"13189","DOI":"10.1021\/bi00249a005","volume":"33","author":"Middleton R.E.","year":"1994","unstructured":"Middleton R.E.; Pheasant D.J.; Miller C.; Purification, reconstitution, and subunit composition of a voltage-gated chloride channel from Torpedo electroplax. Biochemistry 1994,33(45),13189-13198","journal-title":"Biochemistry"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1113\/jphysiol.1995.sp020560","volume":"482","author":"Jentsch T.J.","year":"1995","unstructured":"Jentsch T.J.; G\u00fcnther W.; Pusch M.; Schwappach B.; Properties of voltage-gated chloride channels of the ClC gene family. J Physiol 1995,482(Suppl.),19-25","journal-title":"J Physiol"},{"key":"ref=91","first-page":"141","volume":"14","author":"Jurenka J.S.","year":"2009","unstructured":"Jurenka J.S.; Jurenka. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev 2009,14(2),141-153","journal-title":"Altern Med Rev"},{"key":"ref=92","first-page":"363","volume":"23","author":"Aggarwal B.","year":"2003","unstructured":"Aggarwal B.; Chandra Bharti A.; Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 2003,23(1A),363-398","journal-title":"Anticancer Res"},{"key":"ref=93","first-page":"813","volume":"51","author":"Huang M.T.","year":"1991","unstructured":"Huang M.T.; Lysz T.; Ferraro T.; Abidi T.F.; Laskin J.D.; Conney A.H.; Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 1991,51(3),813-819","journal-title":"Cancer Res"},{"key":"ref=94","first-page":"469","volume":"19","author":"Cho J-W.","year":"2007","unstructured":"Cho J-W.; Lee K-S.; Kim C-W.; Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets. Int J Mol Med 2007,19(3),469-474","journal-title":"Int J Mol Med"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/carcin\/14.5.857","volume":"14","author":"Liu J.Y.","year":"1993","unstructured":"Liu J.Y.; Lin S.J.; Lin J.K.; Inhibitory effects of curcumin on protein kinase C activity induced by 12- O -tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 1993,14(5),857-861","journal-title":"Carcinogenesis"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.2042-7158.1973.tb09131.x","volume":"25","author":"Srimal R.C.","year":"2011","unstructured":"Srimal R.C.; Dhawan B.N.; Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 2011,25(6),447-452","journal-title":"J Pharm Pharmacol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.pain.2012.03.003","volume":"153","author":"Dworkin R.H.","year":"2012","unstructured":"Dworkin R.H.; Turk D.C.; Peirce-Sandner S.; Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain 2012,153(6),1148-1158","journal-title":"Pain"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1097\/j.pain.0000000000000333","volume":"156","author":"Tuttle A.H.","year":"2015","unstructured":"Tuttle A.H.; Tohyama S.; Ramsay T.; Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. Pain 2015,156(12),2616-2626","journal-title":"Pain"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(13)62337-5","volume":"383","author":"Rice A.S.C.","year":"2014","unstructured":"Rice A.S.C.; Dworkin R.H.; McCarthy T.D.; EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: A randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet 2014,383(9929),1637-1647","journal-title":"Lancet"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1212\/WNL.0b013e318297ee69","volume":"81","author":"Dworkin R.H.","year":"2013","unstructured":"Dworkin R.H.; Turk D.C.; Peirce-Sandner S.; Assay sensitivity and study features in neuropathic pain trials: An ACTTION meta-analysis. Neurology 2013,81(1),67-75","journal-title":"Neurology"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrneurol.2013.180","volume":"9","author":"Truini A.","year":"2013","unstructured":"Truini A.; Garcia-Larrea L.; Cruccu G.; Reappraising neuropathic pain in humans-how symptoms help disclose mechanisms. Nature Reviews Neurology 2013,9(10),572-582","journal-title":"Nature Reviews Neurology"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1097\/j.pain.0000000000000266","volume":"156","author":"Demant D.T.","year":"2015","unstructured":"Demant D.T.; Lund K.; Finnerup N.B.; Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype. Pain 2015,156(11),2234-2244","journal-title":"Pain"},{"key":"ref=103","first-page":"651","volume":"24","author":"Satoskar R.R.","year":"1986","unstructured":"Satoskar R.R.; Shah S.J.; Shenoy S.G.; Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol 1986,24(12),651-654","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"ref=104","first-page":"632","volume":"1","author":"Deodhar S.D.","year":"1980","unstructured":"Deodhar S.D.; Sethi R.; Srimal R.C.; Preliminary study on antirheumatic activity of curcumin (diferu-loyl methane). Indian J Med Res PubMed Available from:  [Accessed on: 2022 Feb, 11].1980,1,632-634","journal-title":"Indian J Med Res"},{"key":"ref=105","unstructured":"Blockade of vascular potassium channels during human endotoxemia - Full text view. Available from:  [Accessed on: 2022 Feb, 11]."},{"key":"ref=106","unstructured":"Colchicine counteracting inflammation in covid-19 pneumonia - tabular view. ClinicalTrialsgov Available from:  [Accessed on: 2022 Feb, 11].","journal-title":"ClinicalTrialsgov"},{"key":"ref=107","unstructured":"Amiloride hydrochlorothiazide as treatment of acute inflammation of the optic nerve - full text view. ClinicalTrialsgov Available from:  [Accessed on: 2022 Feb, 11].","journal-title":"ClinicalTrialsgov"},{"key":"ref=108","unstructured":"Impact of lidocaine administration on postoperative complications during lung resection surgery - Full text view. ClinicalTrialsgov Available from:  [Accessed on: 2022 Feb, 11].","journal-title":"ClinicalTrialsgov"},{"key":"ref=109","unstructured":"Lidocaine-ketamine versus ketamine for induction of anesthesia in septic shock patients-full text view. ClinicalTrialsgov Available from:  [Accessed on: 2022 Feb, 11].","journal-title":"ClinicalTrialsgov"},{"key":"ref=110","unstructured":"Predictive factors affecting the efficacy of local tetracycline injection for treatment of post-mastectomy seroma. - tabular view. ClinicalTrialsgov Available from:  [Accessed on: 2022 Feb, 11].","journal-title":"ClinicalTrialsgov"},{"key":"ref=111","unstructured":"Comparison of fimasartan versus amlodipine therapy on carotid plaque inflammation - full text view. ClinicalTrialsgov Available from:  [Accessed on: 2022 Feb, 11].","journal-title":"ClinicalTrialsgov"},{"key":"ref=112","unstructured":"A pilot study of use of calcium channel blocker to decrease inflammation and pain in hereditary pancreatitis - full text view. ClinicalTrialsgov Available from:  [Accessed on: 2022 Feb, 11].","journal-title":"ClinicalTrialsgov"},{"key":"ref=113","unstructured":"Drug-disease interaction in crohn\u2019s disease - tabular view. ClinicalTrialsgov Available from:  [Accessed on: 2022 Feb, 11].","journal-title":"ClinicalTrialsgov"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220819141827","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207733\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220819141827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T07:44:31Z","timestamp":1670744671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207733\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":113,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450123666220819141827","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}